Neo Ivy Capital Management Illumina, Inc. Transaction History

Neo Ivy Capital Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$183.43 - $232.67 $1.72 Million - $2.18 Million	9,366 Added 2329.85%	9,768 $1.83 Million
Q4 2022 Mar 24, 2023	BUY	$187.24 - $242.74 $75,270 - $97,581	402 New	402 $81,000
Q2 2022 Aug 16, 2022	BUY	$181.58 - $368.0 $248,219 - $503,056	1,367 New	1,367 $252,000
Q1 2022 May 16, 2022	SELL	$303.87 - $423.8 $80,525 - $112,307	-265 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$347.28 - $421.83 $92,029 - $111,784	265 New	265 $100,000
Q2 2021 Aug 16, 2021	SELL	$372.84 - $481.5 $173,743 - $224,379	-466 Closed	0 $0
Q1 2021 Oct 07, 2021	BUY	$361.28 - $504.76 $168,356 - $235,218	466 New	466 $179,000
Q4 2020 Feb 16, 2021	SELL	$292.7 - $370.96 $200,206 - $253,736	-684 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$268.51 - $400.74 $183,660 - $274,106	684 New	684 $211,000

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.